ASCO GU 2022 Updates: PARP Inhibitors in First-Line and Subsequent UC Settings

Experts comment on the utility of PARP inhibitors in UC and discuss data presented at ASCO GU 2022.

Related Videos
Experts on GVHD with a patient
Experts on GVHD with a patient
Experts on RCC
Experts on RCC
Experts on RCC
Experts on RCC
Related Content